[go: up one dir, main page]

GB201317932D0 - Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis - Google Patents

Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Info

Publication number
GB201317932D0
GB201317932D0 GB201317932A GB201317932A GB201317932D0 GB 201317932 D0 GB201317932 D0 GB 201317932D0 GB 201317932 A GB201317932 A GB 201317932A GB 201317932 A GB201317932 A GB 201317932A GB 201317932 D0 GB201317932 D0 GB 201317932D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pharmaceutical compositions
cystic fibrosis
novel compounds
cystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201317932A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GAL PAGOS NV
Original Assignee
GAL PAGOS NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GAL PAGOS NV filed Critical GAL PAGOS NV
Priority to GB201317932A priority Critical patent/GB201317932D0/en
Publication of GB201317932D0 publication Critical patent/GB201317932D0/en
Priority to CA3122383A priority patent/CA3122383A1/en
Priority to AU2014264936A priority patent/AU2014264936B2/en
Priority to LU92578A priority patent/LU92578B1/en
Priority to BR112015027964-3A priority patent/BR112015027964B1/en
Priority to PCT/EP2014/001202 priority patent/WO2014180562A1/en
Priority to CA2911453A priority patent/CA2911453C/en
Priority to EP14726516.9A priority patent/EP2994463B1/en
Priority to US14/271,080 priority patent/US9382254B2/en
Priority to CN201480038729.6A priority patent/CN105531268B/en
Priority to MX2015015412A priority patent/MX368263B/en
Priority to JP2016512246A priority patent/JP2016517895A/en
Priority to US15/160,639 priority patent/US9867806B2/en
Priority to JP2019049378A priority patent/JP6792014B2/en
Ceased legal-status Critical Current

Links

GB201317932A 2013-05-07 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Ceased GB201317932D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB201317932A GB201317932D0 (en) 2013-10-10 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
JP2016512246A JP2016517895A (en) 2013-05-07 2014-05-06 Novel compounds for treating cystic fibrosis and pharmaceutical compositions thereof
CA2911453A CA2911453C (en) 2013-05-07 2014-05-06 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis.
US14/271,080 US9382254B2 (en) 2013-05-07 2014-05-06 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
LU92578A LU92578B1 (en) 2013-05-07 2014-05-06 New compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
BR112015027964-3A BR112015027964B1 (en) 2013-05-07 2014-05-06 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) MODULATING COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USE THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS
PCT/EP2014/001202 WO2014180562A1 (en) 2013-05-07 2014-05-06 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
CA3122383A CA3122383A1 (en) 2013-05-07 2014-05-06 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis.
EP14726516.9A EP2994463B1 (en) 2013-05-07 2014-05-06 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
AU2014264936A AU2014264936B2 (en) 2013-05-07 2014-05-06 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
CN201480038729.6A CN105531268B (en) 2013-05-07 2014-05-06 Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis
MX2015015412A MX368263B (en) 2013-05-07 2014-05-06 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis.
US15/160,639 US9867806B2 (en) 2013-05-07 2016-05-20 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
JP2019049378A JP6792014B2 (en) 2013-05-07 2019-03-18 Novel compounds for treating cystic fibrosis and their pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201317932A GB201317932D0 (en) 2013-10-10 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Publications (1)

Publication Number Publication Date
GB201317932D0 true GB201317932D0 (en) 2013-11-27

Family

ID=49679857

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201317932A Ceased GB201317932D0 (en) 2013-05-07 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Country Status (1)

Country Link
GB (1) GB201317932D0 (en)

Similar Documents

Publication Publication Date Title
IL256624B (en) Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP2968285A4 (en) Compounds and methods for the treatment of cystic fibrosis
HRP20181740T1 (en) Pharmaceutical compositions for the treatment of cftr mediated diseases
IL261444A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
PL3021839T3 (en) Compositions for treatment of fibrosis
PL2777689T3 (en) New pharmaceutical composition for the treatment of fungal infections
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL244621A (en) Compositions for the treatment of hypertension and/or fibrosis
IL244622A0 (en) Compositions for the treatment of hypertension and/or fibrosis
GB201315072D0 (en) Novel compounds and pharmaceutical compositions thereoffor the treatment of proliferative disorders
GB201317932D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GB201317935D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GB201308137D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
AU2013901209A0 (en) Compositions and methods for the treatment of cystic fibrosis
TH1601000722A (en) New compounds and their pharmaceutical compositions for treatment cystic fibrosis
AU2012900572A0 (en) Compositions and methods for the treatment of cystic fibrosis
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same
SI2812351T1 (en) Pharmaceutical composition for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)